Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Patent & Trademark Office
Pharma
Viatris gets US agency to review Novo semaglutide patent
After hearing a petition from Viatris, the USPTO will conduct a review to determine the validity of a patent held by Novo Nordisk on semaglutide.
Kevin Dunleavy
Oct 5, 2023 9:10am
Warren asks patent office to scrutinize Merck's Keytruda
Feb 23, 2023 3:25pm
Senate, FDA urge USPTO to alter drug patent application process
Sep 14, 2021 9:15am
Novartis, Regeneron wage Eylea prefilled syringe patent fight
Jul 22, 2020 12:18pm
Alexion's Soliris gets a reprieve with Amgen biosim settlement
Jun 1, 2020 11:31am
Alexion scores 2nd FDA nod for Soliris follow-up Ultomiris
Oct 21, 2019 11:57am
